↓ Skip to main content

Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules

Overview of attention for article published in Frontiers in immunology, May 2022
Altmetric Badge

Mentioned by

twitter
4 X users

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules
Published in
Frontiers in immunology, May 2022
DOI 10.3389/fimmu.2022.823842
Pubmed ID
Authors

Bernardo L. Rapoport, Helen C. Steel, Nomsa Hlatshwayo, Annette J. Theron, Pieter W. A. Meyer, Simon Nayler, Carol-Ann Benn, Teresa Smit, Luyanda L. I. Kwofie, Liezl Heyman, Ronald Anderson

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Other 4 17%
Unspecified 2 8%
Librarian 1 4%
Student > Doctoral Student 1 4%
Student > Ph. D. Student 1 4%
Other 2 8%
Unknown 13 54%
Readers by discipline Count As %
Medicine and Dentistry 4 17%
Immunology and Microbiology 3 13%
Agricultural and Biological Sciences 2 8%
Unspecified 2 8%
Biochemistry, Genetics and Molecular Biology 1 4%
Other 0 0%
Unknown 12 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 June 2022.
All research outputs
#17,865,428
of 26,169,168 outputs
Outputs from Frontiers in immunology
#20,993
of 33,003 outputs
Outputs of similar age
#267,899
of 448,259 outputs
Outputs of similar age from Frontiers in immunology
#1,212
of 1,780 outputs
Altmetric has tracked 26,169,168 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 33,003 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,259 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,780 others from the same source and published within six weeks on either side of this one. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.